Lantheus Holdings Inc

NASDAQ:LNTH   3:59:53 PM EDT
23.26
+0.08 (+0.34%)
Mergers / Acquisitions

Lantheus Acquires Rights To Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (Fap) From Noria

Published: 03/30/2021 12:39 GMT
Lantheus Holdings Inc (LNTH) - Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (fap) From Noria.
Lantheus Holdings Inc - Noria Will Drive Early Clinical Development of Nti-1309.
Lantheus Holdings Inc - Terms of Transaction Include an Upfront License and Development Fee to Noria.
Lantheus Holdings Inc - Terms Include Certain Development and Regulatory Milestones, and Royalties If Nti-1309 is Commercialized.